Lena Lee, Contract Specialist

Lena Lee serves as a Contract Specialist within the National Cancer Institute, part of the National Institutes of Health under the Department of Health and Human Services, where she manages complex procurement actions supporting cutting-edge cancer research infrastructure. Her role centers on acquiring advanced analytical laboratory instruments, precision diagnostic equipment, and specialized technical services critical to genomic analysis and translational research. She ensures compliance with federal acquisition regulations while aligning procurement strategies with NCI’s mission to accelerate precision medicine through high-capability scientific platforms, frequently handling sole-source, competitive, and performance-based contracts for mission-critical research tools. Lena maintains a primary working relationship with Roche Diagnostics Corporation, a leading provider of clinical diagnostics and laboratory automation systems, reflecting her focus on high-precision, regulated medical technologies. Her procurement patterns indicate sustained vendor partnerships with established manufacturers and service providers capable of meeting stringent scientific and regulatory standards, including validation, calibration, and lifecycle support for laboratory instrumentation. These relationships are characterized by technical collaboration, long-term service agreements, and adherence to quality management systems required for clinical research environments. Her contracting approach is overwhelmingly non-set-aside, with 90.8% of awards issued under open competition, reflecting the specialized nature of the equipment and services procured. While small business participation is limited, she consistently supports Total Small Business Set-Asides (8.3%) and occasionally awards to Service-Disabled Veteran-Owned Small Businesses (0.9%), aligning with broader HHS socioeconomic goals where technical capability permits. Lena’s procurement portfolio is dominated by NAICS 334516 (Analytical Laboratory Instrument Manufacturing), underscoring her expertise in acquiring mass spectrometers, next-generation sequencers, and flow cytometry systems. She also regularly procures maintenance and calibration services under NAICS 811210 and 811219, ensuring operational continuity of high-value research equipment. Her technical domain spans clinical diagnostics, molecular analysis, and laboratory automation, requiring deep familiarity with FDA-regulated devices and ISO-compliant instrumentation.